DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Lineage Cell Therapeutics Q4 EPS $(0.03) Beats $(0.05) Estimate, Sales $1.241M Beat $1.03M Estimate

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 91.67 percent increase over losses of $(0.36) per share

Benzinga · 03/12/2020 20:25

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 91.67 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $1.241 million which beat the analyst consensus estimate of $1.03 million by 20.49 percent. This is a 63.72 percent increase over sales of $758 thousand the same period last year.